Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 14 of 84 for:    Developmental Disabilities | ( Map: Canada )

Dialectical Behaviour Group Therapy for Adults With Intellectual Disabilities

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02919826
Recruitment Status : Unknown
Verified September 2016 by Dr. Jessica Jones, Queen's University.
Recruitment status was:  Recruiting
First Posted : September 29, 2016
Last Update Posted : September 29, 2016
Sponsor:
Collaborator:
Providence Care
Information provided by (Responsible Party):
Dr. Jessica Jones, Queen's University

Brief Summary:
To determine the feasibility and effectiveness of a RCT of an adapted DBT group delivered to individuals with ID and emotional dysregulation.

Condition or disease Intervention/treatment Phase
Intellectual Disability Behavioral: Adapted Dialectical Behaviour Therapy Not Applicable

  Show Detailed Description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 18 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Adapting and Evaluating Dialectical Behaviour Group Therapy for Adults With Dual Diagnosis (Intellectual Disabilities With Psychiatric Disorder)
Study Start Date : August 2016
Estimated Primary Completion Date : September 2017
Estimated Study Completion Date : March 2018

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: DBT Group
Adapted Dialectical Behaviour Therapy
Behavioral: Adapted Dialectical Behaviour Therapy
12 weekly sessions of DBT group therapy

No Intervention: Control Arm
People in this group will receive treatment as usual



Primary Outcome Measures :
  1. Change in Difficulties in Emotional Regulation Scale (Gratz & Roemner, 2004) [ Time Frame: Pre treatment and 12 week post treatment ]

Secondary Outcome Measures :
  1. Change in Novaco Anger Scale: Part B (Provocation Index)(Novaco, 2003) [ Time Frame: Pre treatment and 12 week post treatment ]
  2. Change in Reiss Scale of Dual Diagnosis 38Q (IDS, 1987) [ Time Frame: Pre treatment and 12 week post treatment ]
  3. Change in Adapted Emotion Regulation Checklist (Adapted with permission from Dante Cicchetti by Jessica Jones) [ Time Frame: Pretreatment and 12 week post treatment ]
  4. Global Impression of Change [ Time Frame: 12 week Post Treatment ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 75 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Diagnosis of Mild or Moderate Intellectual Disability
  • Symptoms of emotional and behavioural difficulties e.g. emotional dysregulation
  • Dedicated caregiver to accompany and attend all sessions

Exclusion Criteria:

  • Diagnosis of Autism Spectrum Disorder
  • Profound or Severe Intellectual Disability
  • Acute psychosis interfering with daily functioning

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02919826


Contacts
Layout table for location contacts
Contact: Ashleigh Blinkhorn, MSc 16135484417 ext 1105 blinkhrn@queensu.ca
Contact: Jessica Jones, PhD 16135497944 jonesj@queensu.ca

Locations
Layout table for location information
Canada, Ontario
Division of Developmental Disabilities, 191 Portsmouth Avenue Recruiting
Kingston, Ontario, Canada, K7M 8A6
Contact: Jessica Jones, PhD    16135497944    jonesj@queensu.ca   
Contact: Muhammad Ayub, MRCPsych    16135497944    ma84@queensu.ca   
Sponsors and Collaborators
Queen's University
Providence Care
Investigators
Layout table for investigator information
Principal Investigator: Jessica Jones, PhD Queen's University, Kingston

Layout table for additonal information
Responsible Party: Dr. Jessica Jones, Principal Investigator, Queen's University
ClinicalTrials.gov Identifier: NCT02919826     History of Changes
Other Study ID Numbers: PSIY-511-15
First Posted: September 29, 2016    Key Record Dates
Last Update Posted: September 29, 2016
Last Verified: September 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Additional relevant MeSH terms:
Layout table for MeSH terms
Intellectual Disability
Neurobehavioral Manifestations
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms
Neurodevelopmental Disorders
Mental Disorders